Indian Pharmaceutical Alliance

Indian Pharmaceutical Alliance IPA is an alliance of 23 leading Indian pharmaceutical companies, committed to patient care in India and across the world.

Nilesh Gupta, Managing Director - Lupin India, welcomes the GST reforms as a pivotal move to make medicines more afforda...
19/09/2025

Nilesh Gupta, Managing Director - Lupin India, welcomes the GST reforms as a pivotal move to make medicines more affordable and accessible, reinforcing the industry’s shared commitment to ensuring quality care reaches every patient who needs it.

PMO India | Narendra Modi | Ministry of Health and Family Welfare, Government of India | Department of Pharmaceuticals | J.P.Nadda | MyGovIndia | Ministry of Finance, Government of India | Nirmala Sitharaman | Piyush Goyal | Department of Commerce, GoI

Calling the GST reforms a significant step, Satish Reddy, Chairman, Dr. Reddy's Laboratories Ltd., emphasized that reduc...
18/09/2025

Calling the GST reforms a significant step, Satish Reddy, Chairman, Dr. Reddy's Laboratories Ltd., emphasized that reduced tax rates on life-saving drugs will improve healthcare access and directly benefit millions of patients across India. He noted that the reform underscores the industry’s commitment to affordability and patient-centric care.

PMO India | Narendra Modi | Ministry of Health and Family Welfare, Government of India | Department of Pharmaceuticals | J.P.Nadda | MyGovIndia | Ministry of Finance, Government of India | Nirmala Sitharaman | Piyush Goyal | Department of Commerce, GoI

On , we reaffirm our commitment to ‘Safe care for every newborn and every child.’Children are among the most vulnerable...
17/09/2025

On , we reaffirm our commitment to ‘Safe care for every newborn and every child.’

Children are among the most vulnerable; they deserve the highest assurance of safety in hospitals, in communities, and in every dose of medicine they receive.

At IPA, we are committed to strengthening trust in medicines by upholding global safety standards, ensuring that every child has access to the care they need and deserve.

For Arjun Juneja, Chief Operating Officer - Mankind Pharma Limited, the GST reforms mark a pivotal moment in India’s hea...
10/09/2025

For Arjun Juneja, Chief Operating Officer - Mankind Pharma Limited, the GST reforms mark a pivotal moment in India’s healthcare journey. They make life-saving treatments more affordable for patients and open new opportunities for innovators, startups, MSMEs, and CDMOs - strengthening India’s path towards a healthier, self-reliant future.

PMO India | Narendra Modi | Ministry of Health and Family Welfare, Government of India | Department of Pharmaceuticals | J.P.Nadda | MyGovIndia | Ministry of Finance, Government of India | Nirmala Sitharaman | Piyush Goyal | Department of Commerce, GoI

Dr. Sharvil Patel, Vice President of the Indian Pharmaceutical Alliance and Managing Director of Zydus Lifesciences, bel...
09/09/2025

Dr. Sharvil Patel, Vice President of the Indian Pharmaceutical Alliance and Managing Director of Zydus Lifesciences, believes the recent GST reforms are a game-changer for patient care across India. These reforms will not only ease the burden of care for families but also improve patient adherence to therapy by making essential medicines more affordable. This, in turn, will strengthen India's journey towards accessible and affordable healthcare for all.

PMO India | Narendra Modi | Ministry of Health and Family Welfare, Government of India | Department of Pharmaceuticals | J.P.Nadda | MyGovIndia | Ministry of Finance, Government of India | Nirmala Sitharaman | Piyush Goyal | Department of Commerce, GoI

Dilip Shanghvi, Executive Chairman of Sun Pharmaceutical Industries Limited, welcomes the GST reforms as a significant s...
09/09/2025

Dilip Shanghvi, Executive Chairman of Sun Pharmaceutical Industries Limited, welcomes the GST reforms as a significant step in making medicines more accessible and remains committed to passing the benefits on to patients across India.

PMO India | Narendra Modi | Ministry of Health and Family Welfare, Government of India | Department of Pharmaceuticals | J.P.Nadda | MyGovIndia | Ministry of Finance, Government of India | Nirmala Sitharaman | Piyush Goyal | Department of Commerce, GoI

Samir Mehta, President - Indian Pharmaceutical Alliance and Chairman - Torrent Pharmaceuticals Limited, highlights how G...
08/09/2025

Samir Mehta, President - Indian Pharmaceutical Alliance and Chairman - Torrent Pharmaceuticals Limited, highlights how GST reforms can expand access to affordable medicines and strengthen India’s journey towards a healthier, Atmanirbhar Bharat.

PMO India | Narendra Modi | Ministry of Health and Family Welfare, Government of India | Department of Pharmaceuticals | J.P.Nadda | MyGovIndia | Ministry of Finance, Government of India | Nirmala Sitharaman | Piyush Goyal | Department of Commerce, GoI

Shridhar Narayanan, Senior Technical Advisor, Indian Pharmaceutical Alliance, shares his perspective on a pivotal moment...
08/09/2025

Shridhar Narayanan, Senior Technical Advisor, Indian Pharmaceutical Alliance, shares his perspective on a pivotal moment for India's pharmaceutical industry. He explains how the country is moving beyond its traditional role as a generics leader to become a global hub for research and development, driven by a new focus on innovation and drug discovery.

Read more: https://tinyurl.com/35yx8juh

Chronicle Pharmabiz

Indian Pharmaceutical Alliance (IPA) sincerely thanks Hon’ble Prime Minister Shri Narendra Modi Ji and the Government of...
05/09/2025

Indian Pharmaceutical Alliance (IPA) sincerely thanks Hon’ble Prime Minister Shri Narendra Modi Ji and the Government of India for the visionary GST reforms that make essential medicines more affordable and accessible. By granting GST exemption on 36 medicines and reducing GST on many others from 12% to 5%, this step brings immense relief to patients and their families across India. Together, let’s build a healthier, stronger, Atmanirbhar Bharat.

PMO India | Narendra Modi | Ministry of Health and Family Welfare, Government of India | Department of Pharmaceuticals | J.P.Nadda | MyGovIndia | Ministry of Finance, Government of India | Nirmala Sitharaman | Piyush Goyal | Department of Commerce, GoI

Abbott | Ajanta Pharma | Alkem Laboratories Ltd. | Alembic Pharmaceuticals Ltd | AUROBINDO PHARMA LTD | Cadila Pharmaceuticals Ltd. | Cipla | Dr. Reddy's Laboratories Ltd. | Emcure Pharmaceuticals Limited | Glenmark Pharmaceuticals | Intas Pharmaceuticals | Ipca | Lupin India | Macleods Pharmaceuticals LTD | Mankind Pharma Limited | Micro Labs Ltd. | NATCO Pharma | Panacea Biotec | Piramal Pharma Ltd | Sun Pharmaceutical Industries Limited | Torrent Pharmaceuticals Limited | USV PRIVATE LIMITED | Zydus Lifesciences

Sudarshan Jain, Secretary General - Indian Pharmaceutical Alliance (IPA), shares his perspective on the recent GST refor...
04/09/2025

Sudarshan Jain, Secretary General - Indian Pharmaceutical Alliance (IPA), shares his perspective on the recent GST reforms. The Government’s decision to exempt life-saving and cancer medicines from GST, a step that will bring direct relief to patients and their families. Equally, the reduction in GST on a wide range of medicines from 12% to 5% will help ease the overall treatment burden and make essential therapies more affordable.

These reforms will improve the accessibility of medicines, ensure wider availability across healthcare settings, and contribute positively to the Government’s vision of affordable healthcare for all. The pharmaceutical industry remains committed to working alongside policymakers to further enhance patient access and advance India’s healthcare outcomes.

PMO India | Narendra Modi | Ministry of Health and Family Welfare, Government of India | Department of Pharmaceuticals | J.P.Nadda | MyGovIndia | Ministry of Finance, Government of India | Nirmala Sitharaman

Address

Santacruz

Website

Alerts

Be the first to know and let us send you an email when Indian Pharmaceutical Alliance posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Indian Pharmaceutical Alliance:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

About IPA

The Indian Pharmaceutical Alliance (IPA) was established in the year 1999 in Mumbai. IPA represents research-based National Pharmaceutical Companies in India. The IPA works closely with the Government on policy-related matters and seeks to imbibe the experiences of the generic pharmaceutical industry internationally. It is also partnering with the Government in the evolution of a patent regime and up-gradation of the regulatory regime in India.

It consists of 24 member companies. IPA accounts for over 85 percent of the private sector investment in pharmaceutical research and development. We contribute more than 80 percent of the country's exports of drugs and pharmaceuticals and service over 57 percent of the domestic market.